{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:58:55Z","timestamp":1780333135125,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":691,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870346"],"award-info":[{"award-number":["81870346"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971712"],"award-info":[{"award-number":["81971712"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971758"],"award-info":[{"award-number":["81971758"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jvs.2021.10.051","type":"journal-article","created":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T09:54:02Z","timestamp":1636883642000},"page":"1440-1449.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["A meta-analysis of randomized controlled trials on therapeutic efficacy and safety of autologous cell therapy for atherosclerosis obliterans"],"prefix":"10.1016","volume":"75","author":[{"given":"Hongji","family":"Pu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-0957","authenticated-orcid":false,"given":"Xinwu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2021.10.051_bib1","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/01.CIR.0000137913.26087.F0","article-title":"Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000","volume":"110","author":"Selvin","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2021.10.051_bib2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ije\/20.2.384","article-title":"Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population","volume":"20","author":"Fowkes","year":"1991","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jvs.2021.10.051_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","article-title":"Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease","volume":"118","author":"Herrington","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2021.10.051_bib4","doi-asserted-by":"crossref","first-page":"j5842","DOI":"10.1136\/bmj.j5842","article-title":"Peripheral artery disease","volume":"360","author":"Morley","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2021.10.051_bib5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/CIRCRESAHA.116.308334","article-title":"Atherosclerosis: successes, surprises, and future challenges","volume":"118","author":"Libby","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2021.10.051_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrcardio.2016.179","article-title":"Peripheral artery disease: epidemiology and global perspectives","volume":"14","author":"Fowkes","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jvs.2021.10.051_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-0034-1393969","article-title":"Pharmacology in peripheral arterial disease: what the interventional radiologist needs to know","volume":"31","author":"Atturu","year":"2014","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.jvs.2021.10.051_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12262-009-0059-7","article-title":"Stem cell therapy for critical limb ischaemia - a review","volume":"71","author":"Das","year":"2009","journal-title":"Indian J Surg"},{"key":"10.1016\/j.jvs.2021.10.051_bib9","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1161\/01.CIR.0000105722.96112.67","article-title":"Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells","volume":"108","author":"Hu","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2021.10.051_bib10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/01.RES.0000137878.26174.66","article-title":"Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences","volume":"95","author":"Kinnaird","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2021.10.051_bib11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/sctm.18-0025","article-title":"Cell therapy for chronic limb-threatening ischemia: current evidence and future directions","volume":"7","author":"Teraa","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jvs.2021.10.051_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2009.08.033","article-title":"Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature","volume":"209","author":"Fadini","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2021.10.051_bib13","doi-asserted-by":"crossref","first-page":"e0125032","DOI":"10.1371\/journal.pone.0125032","article-title":"Therapeutic efficacy of stem cell-based therapy in peripheral arterial disease: a meta-analysis","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jvs.2021.10.051_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13287-019-1254-5","article-title":"Autologous stem cell therapy for peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Gao","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jvs.2021.10.051_bib15","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2021.10.051_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2021.10.051_bib17","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2021.10.051_bib18","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2021.10.051_bib19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1253\/circj.70.1093","article-title":"Granulocyte colony-stimulating factor: a noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease","volume":"70","author":"Arai","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.jvs.2021.10.051_bib20","first-page":"155","article-title":"Bone-marrow cells in therapy of critical limb ischaemia of lower extremities - own experience","volume":"12","author":"Barc","year":"2006","journal-title":"Acta Angiolog"},{"key":"10.1016\/j.jvs.2021.10.051_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1479-5876-9-165","article-title":"The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design","volume":"9","author":"Benoit","year":"2011","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jvs.2021.10.051_bib22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/SLA.0000000000002896","article-title":"No clinical benefit of intramuscular delivery of bone marrow-derived mononuclear cells in nonreconstructable peripheral arterial disease: results of a phase-III randomized-controlled trial","volume":"268","author":"Lindeman","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvs.2021.10.051_bib23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/CIRCINTERVENTIONS.112.968321","article-title":"A\u00a0randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia","volume":"5","author":"Losordo","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2021.10.051_bib24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.diabres.2010.12.010","article-title":"Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial","volume":"92","author":"Lu","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jvs.2021.10.051_bib25","first-page":"1060","article-title":"A\u00a0randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia","volume":"78","author":"Perin","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2021.10.051_bib26","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1253\/circj.CJ-17-0045","article-title":"Autologous bone marrow mononuclear cell implantation and its impact on the outcome of patients with critical limb ischemia: results of a randomized, double-blind, placebo-controlled trial","volume":"81","author":"Pignon","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.jvs.2021.10.051_bib27","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3727\/096368910X514170","article-title":"Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer","volume":"19","author":"Prochazka","year":"2010","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jvs.2021.10.051_bib28","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.jcyt.2014.07.011","article-title":"Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial","volume":"16","author":"Raval","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jvs.2021.10.051_bib29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5114\/aoms.2013.39935","article-title":"Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia","volume":"11","author":"Skora","year":"2015","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jvs.2021.10.051_bib30","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.114.012913","volume":"131","author":"Teraa","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2021.10.051_bib31","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejvs.2019.11.025","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"59","author":"Conte","year":"2020","journal-title":"Eur J Vasc Endovasc"},{"key":"10.1016\/j.jvs.2021.10.051_bib32","first-page":"CD012794","article-title":"Stem cell therapy for treatment of thromboangiitis obliterans (Buerger\u2019s disease)","volume":"10","author":"Cacione","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2021.10.051_bib33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13287-017-0683-2","article-title":"Meta-analysis on the treatment of diabetic foot ulcers with autologous stem cells","volume":"8","author":"Guo","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jvs.2021.10.051_bib34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1253\/circj.71.196","article-title":"Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia","volume":"71","author":"Kajiguchi","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.jvs.2021.10.051_bib35","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1253\/circj.CJ-17-0510","article-title":"Long-term clinical outcomes survey of bone marrow-derived cell therapy in critical limb ischemia in Japan","volume":"82","author":"Kondo","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.jvs.2021.10.051_bib36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/1358863X9700200109","article-title":"Thromboangiitis obliterans (Buerger\u2019s disease)","volume":"2","author":"Aqel","year":"1997","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvs.2021.10.051_bib37","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1056\/NEJM200009213431207","article-title":"Thromboangiitis obliterans (Buerger\u2019s disease)","volume":"343","author":"Olin","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.jvs.2021.10.051_bib38","first-page":"S255","article-title":"Identification of risk factors related to poor angiogenic potency of bone marrow cells from different patients","volume":"120","author":"Li","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2021.10.051_bib39","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCRESAHA.116.309315","article-title":"Task for today: complete the puzzle of circulating stem cells and the atherosclerotic burden","volume":"119","author":"Fadini","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2021.10.051_bib40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/CIRCRESAHA.116.308802","article-title":"Circulating progenitor cells identify peripheral arterial disease in patients with coronary artery disease","volume":"119","author":"Hayek","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2021.10.051_bib41","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/CIRCRESAHA.116.308366","article-title":"Levels of circulating progenitor cells, cardiovascular outcomes and death: a meta-analysis of prospective observational studies","volume":"118","author":"Rigato","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2021.10.051_bib42","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3727\/096368912X636948","article-title":"No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia","volume":"21","author":"Klepanec","year":"2012","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jvs.2021.10.051_bib43","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1160\/TH07-02-0137","article-title":"Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans","volume":"98","author":"Huang","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvs.2021.10.051_bib44","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/bmt.2010.110","article-title":"Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASO: pooled analysis for long-term prognosis","volume":"46","author":"Onodera","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jvs.2021.10.051_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/mthe.2002.0638","article-title":"Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study","volume":"6","author":"M\u00e4kinen","year":"2002","journal-title":"Mol Ther"},{"key":"10.1016\/j.jvs.2021.10.051_bib46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/1358863X18817610","article-title":"SDF-1 plasmid treatment for patients with peripheral artery disease (STOP-PAD): randomized, double-blind, placebo-controlled clinical trial","volume":"24","author":"Shishehbor","year":"2019","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvs.2021.10.051_bib47","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/1526602820919951","article-title":"Stromal cell-derived factor-1 plasmid treatment for patients with peripheral artery disease (STOP-PAD) trial: six-month results","volume":"27","author":"Hammad","year":"2020","journal-title":"J\u00a0Endovasc Ther"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074152142102437X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074152142102437X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:35:27Z","timestamp":1760042127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074152142102437X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S074152142102437X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2021.10.051","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A meta-analysis of randomized controlled trials on therapeutic efficacy and safety of autologous cell therapy for atherosclerosis obliterans","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2021.10.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}